RESUMEN

INTRODUCTION: The Latin American Spanish version of the Face-Name Associative Memory Exam (LAS-FNAME) has shown promise in identifying cognitive changes in those at risk for Alzheimer's disease (AD). However, its applicability for Mild Cognitive Impairment (MCI) detection in the Latin American population remains unexplored. This study aims to analyze the psychometric properties in terms of validity and reliability and diagnostic performance of the LAS-FNAME for the detection of memory disorders in patients with amnestic MCI (aMCI). MATERIALS AND METHODS: The study included 31 participants with aMCI, diagnosed by a neurologist according to Petersen's criteria, and 19 healthy controls. Inclusion criteria for the aMCI group were to be 60 years of age or older, report cognitive complaints, have a memory test score (Craft Story 21) below a -1.5 z-score and have preserved functioning in activities of daily living. Participants completed LAS-FNAME and a comprehensive neuropsychological assessment. RESULTS: LAS-FNAME showed the ability to discriminate against healthy controls from patients with aMCI (AUC= 75) in comparison with a gold-standard memory test (AUC = 69.1). LAS-FNAME also showed evidence of concurrent and divergent validity with a standard memory test (RAVLT) (r = 0.58, p < .001) and with an attention task (Digit Span) (r = -0.37, p = .06). Finally, the reliability index was very high (α = 0.88). DISCUSSION: LAS-FNAME effectively distinguished aMCI patients from healthy controls, suggesting its potential for detecting early cognitive changes in Alzheimer's prodromal stages among Spanish speakers.

RESUMEN

JUSTIFICACIÓN: debido a la crisis sanitaria provocada por el virus SARS-COV-2, resulta necesaria la implicación de la farmacia comunitaria. Por ello, los Colegios Oficiales de Farmacéuticos de Aragón junto con el Departamento de Sanidad del Gobierno de Aragón, firman un acuerdo de colaboración para la realización de test para la detección de antígenos de SARS-COV-2 a pacientes asintomáticos.OBJETIVOS: -Emisión de certificados: Certificados COVID Digitales de la UE y Certificados privados emitidos por las farmacias.-Detección de pacientes asintomáticos.-Controlar la transmisión del COVID-19 mediante el registro y notificación de los resultados positivos obtenidos al Departamento de Sanidad del Gobierno de Aragón.MATERIAL: para adherirse a este acuerdo, las farmacias han de cumplir una serie de requisitos que garanticen la calidad y la seguridad del servicio. •Comunicación previa al colegio profesional y firma de la declaración responsable.• Consentimiento informado en el que el paciente autoriza la realización del test, así como el tratamiento de sus datos personales.• Zona diferenciada para la realización del test que garantice confidencialidad y seguridad.• Test de diagnóstico/autodiagnóstico de antígenos de COVID-19 (autorizados por la UE). •Acceso a la plataforma web de generación de Certificado COVID Digital de la UE.MÉTODOS: •Paciente asintomático solicita la realización del test de antígenos.• Firma del consentimiento informado.• Realización del test.• Registro del resultado. o En caso positivo: Notificación a través de la plataforma web.Posibilidad de emitir un certificado COVID privado emitido por la farmacia. Indicar aislamiento y contactar con asistencia sanitaria o En caso negativo:Emisión de certificado, en función del test utilizado. (AU)

Asunto(s)

RESUMEN

PURPOSE: Incident learning plays a key role in improving quality and safety in a wide range of industries and medical disciplines. However, implementing an effective incident learning system is complex, especially in radiation oncology. One current barrier is the lack of technical standards to guide users or developers. This report, the product of an initiative by the Work Group on Prevention of Errors in Radiation Oncology of the American Association of Physicists in Medicine, provides technical recommendations for the content and structure of incident learning databases in radiation oncology. METHODS: A panel of experts was assembled and tasked with developing consensus recommendations in five key areas: definitions, process maps, severity scales, causality taxonomy, and data elements. Experts included representatives from all major North American radiation oncology organizations as well as users and developers of public and in-house reporting systems with over two decades of collective experience. Recommendations were developed that take into account existing incident learning systems as well as the requirements of outside agencies. RESULTS: Consensus recommendations are provided for the five major topic areas. In the process mapping task, 91 common steps were identified for external beam radiation therapy and 88 in brachytherapy. A novel feature of the process maps is the identification of "safety barriers," also known as critical control points, which are any process steps whose primary function is to prevent errors or mistakes from occurring or propagating through the radiotherapy workflow. Other recommendations include a ten-level medical severity scale designed to reflect the observed or estimated harm to a patient, a radiation oncology-specific root causes table to facilitate and regularize root-cause analyses, and recommendations for data elements and structures to aid in development of electronic databases. Also presented is a list of key functional requirements of any reporting system. CONCLUSIONS: Incident learning is recognized as an invaluable tool for improving the quality and safety of treatments. The consensus recommendations in this report are intended to facilitate the implementation of such systems within individual clinics as well as on broader national and international scales.

Asunto(s)

RESUMEN

Persons infected with the human immunodeficiency virus (HIV) can develop a variety of dermatoses in which the primary lesions are scaly papules or plaques. These dermatoses can be the presenting clinical manifestations of HIV infection. Depending on the degree of immune dysfunction, the clinical and histopathologic appearance may be typical or quite unusual.

Asunto(s)